271 related articles for article (PubMed ID: 27714060)
1. Serum metabolomics of Indian women with polycystic ovary syndrome using
RoyChoudhury S; Mishra BP; Khan T; Chattopadhayay R; Lodh I; Datta Ray C; Bose G; Sarkar HS; Srivastava S; Joshi MV; Chakravarty B; Chaudhury K
Mol Biosyst; 2016 Oct; 12(11):3407-3416. PubMed ID: 27714060
[TBL] [Abstract][Full Text] [Related]
2. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.
Sun L; Hu W; Liu Q; Hao Q; Sun B; Zhang Q; Mao S; Qiao J; Yan X
J Proteome Res; 2012 May; 11(5):2937-46. PubMed ID: 22428626
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study.
Atiomo W; Daykin CA
Mol Hum Reprod; 2012 Nov; 18(11):546-53. PubMed ID: 22809877
[TBL] [Abstract][Full Text] [Related]
5. NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
Selen ES; Bolandnazar Z; Tonelli M; Bütz DE; Haviland JA; Porter WP; Assadi-Porter FM
J Proteome Res; 2015 Aug; 14(8):3284-91. PubMed ID: 26076986
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach.
Dong F; Deng D; Chen H; Cheng W; Li Q; Luo R; Ding S
Anal Bioanal Chem; 2015 Jun; 407(16):4683-95. PubMed ID: 25860656
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome.
Hou E; Zhao Y; Hang J; Qiao J
Biomed Chromatogr; 2021 Mar; 35(3):e4993. PubMed ID: 32986877
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.
Zhao Y; Fu L; Li R; Wang LN; Yang Y; Liu NN; Zhang CM; Wang Y; Liu P; Tu BB; Zhang X; Qiao J
BMC Med; 2012 Nov; 10():153. PubMed ID: 23198915
[TBL] [Abstract][Full Text] [Related]
9. Investigating correlations in the altered metabolic profiles of obese and diabetic subjects in a South Indian Asian population using an NMR-based metabolomic approach.
Gogna N; Krishna M; Oommen AM; Dorai K
Mol Biosyst; 2015 Feb; 11(2):595-606. PubMed ID: 25464928
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry.
Jia C; Xu H; Xu Y; Xu Y; Shi Q
Mol Reprod Dev; 2019 Mar; 86(3):292-297. PubMed ID: 30624822
[TBL] [Abstract][Full Text] [Related]
11. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
12. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry.
Zhao X; Xu F; Qi B; Hao S; Li Y; Li Y; Zou L; Lu C; Xu G; Hou L
J Proteome Res; 2014 Feb; 13(2):1101-11. PubMed ID: 24428203
[TBL] [Abstract][Full Text] [Related]
14. Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique.
Buszewska-Forajta M; Rachoń D; Stefaniak A; Wawrzyniak R; Konieczna A; Kowalewska A; Markuszewski MJ
J Steroid Biochem Mol Biol; 2019 Feb; 186():176-184. PubMed ID: 30670174
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics in polycystic ovary syndrome.
Murri M; Insenser M; Escobar-Morreale HF
Clin Chim Acta; 2014 Feb; 429():181-8. PubMed ID: 24368231
[TBL] [Abstract][Full Text] [Related]
16. NMR-based metabonomics for understanding the influence of dormant female genital tuberculosis on metabolism of the human endometrium.
Subramani E; Jothiramajayam M; Dutta M; Chakravorty D; Joshi M; Srivastava S; Mukherjee A; Datta Ray C; Chakravarty BN; Chaudhury K
Hum Reprod; 2016 Apr; 31(4):854-65. PubMed ID: 26851602
[TBL] [Abstract][Full Text] [Related]
17. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
18. Untargeted metabolomics analysis of serum and follicular fluid samples from women with polycystic ovary syndrome.
Xu WL; Liu GY; Zhang N; Ren J; Li XY; Li YQ; Chen Y; Liu JY
Minerva Endocrinol (Torino); 2023 Jun; 48(2):160-171. PubMed ID: 33103870
[TBL] [Abstract][Full Text] [Related]
19. Role of kisspeptin in polycystic ovarian syndrome: A metabolomics study.
Zhao T; Xiao X; Li L; Tao X; He W; Zhang Q; Wu X; Yuan T
Clin Endocrinol (Oxf); 2023 Sep; 99(3):315-325. PubMed ID: 36843187
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
